Accuronix Therapeutics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$192K
- Investors
-
3
Accuronix Therapeutics General Information
Description
Operator of a clinical-stage biopharmaceutical company intended to develop novel cancer therapies. The company's therapies are based on technology that selectively targets Sigma-2 receptors overexpressed on cancer cells, enabling doctors to reduce toxicity risk.
Contact Information
Website
www.accuronix.comCorporate Office
- 4340 Duncan Avenue
- Suite 210
- Saint Louis, MO 63110
- United States
Corporate Office
- 4340 Duncan Avenue
- Suite 210
- Saint Louis, MO 63110
- United States
Accuronix Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Seed Round | 30-Sep-2020 | $192K | 00000 | Completed | Generating Revenue | |
| 6. Grant | 23-Sep-2019 | 00.000 | 00000 | Completed | Generating Revenue | |
| 5. Seed Round | Cancelled | Generating Revenue | ||||
| 4. Grant | 01-Sep-2019 | 00000 | 00000 | Completed | Generating Revenue | |
| 3. Early Stage VC | 28-Jan-2016 | 00000 | 00000 | Completed | Generating Revenue | |
| 2. Early Stage VC | $25K | $25K | Completed | Startup | ||
| 1. Spin-Off | 01-Jan-2016 | Completed | Startup |
Accuronix Therapeutics Comparisons
Industry
Financing
Details
000000
000000
Accuronix Therapeutics Competitors (27)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NexImmune | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
| ImmunOs Therapeutics | Venture Capital-Backed | Schlieren, Switzerland | 00 | 0000 | 00000000000 | 0000 |
| Arvinas | Formerly VC-backed | New Haven, CT | 000 | 00000 | 000000000 | 00000 |
| Kymera Therapeutics | Formerly VC-backed | Watertown, MA | 000 | 00.000 | 00000000 | 00.000 |
| Cullgen | Venture Capital-Backed | San Diego, CA | 000 | 00000 | 00000000000 | 00000 |
Accuronix Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Accuronix Therapeutics Executive Team (5)
| Name | Title | Board Seat |
|---|---|---|
| Bradley Keller Ph.D | Chief Executive Officer, President, Secretary & Board Member | |
| Robert Mach Ph.D | Co-Founder | |
| William Hawkins MD | Co-Founder | |
| Charles Bolten | Executive |
Accuronix Therapeutics Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Bradley Keller Ph.D | Accuronix Therapeutics | Chief Executive Officer, President, Secretary & Board Member | 000 0000 |
| Tim Campbell | Self | Board Member | 000 0000 |
Accuronix Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Accuronix Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Cancer Institute | Government | 000 0000 | 000000 0 | |
| BioGenerator Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
| Missouri Technology Corporation | Venture Capital | Minority | 000 0000 | 000000 0 |
Accuronix Therapeutics FAQs
-
When was Accuronix Therapeutics founded?
Accuronix Therapeutics was founded in 2015.
-
Who is the founder of Accuronix Therapeutics?
Robert Mach Ph.D and William Hawkins MD are the founders of Accuronix Therapeutics.
-
Who is the CEO of Accuronix Therapeutics?
Bradley Keller Ph.D is the CEO of Accuronix Therapeutics.
-
Where is Accuronix Therapeutics headquartered?
Accuronix Therapeutics is headquartered in Saint Louis, MO.
-
What is the size of Accuronix Therapeutics?
Accuronix Therapeutics has 3 total employees.
-
What industry is Accuronix Therapeutics in?
Accuronix Therapeutics’s primary industry is Biotechnology.
-
Is Accuronix Therapeutics a private or public company?
Accuronix Therapeutics is a Private company.
-
What is Accuronix Therapeutics’s current revenue?
The current revenue for Accuronix Therapeutics is 000000.
-
How much funding has Accuronix Therapeutics raised over time?
Accuronix Therapeutics has raised $842K.
-
Who are Accuronix Therapeutics’s investors?
National Cancer Institute, BioGenerator Ventures, and Missouri Technology Corporation have invested in Accuronix Therapeutics.
-
Who are Accuronix Therapeutics’s competitors?
NexImmune, ImmunOs Therapeutics, Arvinas, Kymera Therapeutics, and Cullgen are some of the 27 competitors of Accuronix Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
